These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 26219932

  • 1. Evaluation of the In Vitro Efficacy of Sevelamer Hydrochloride and Sevelamer Carbonate.
    Yang Y, Mohammad A, Berendt RT, Carlin A, Khan MA, Faustino PJ.
    J Pharm Sci; 2016 Feb; 105(2):864-875. PubMed ID: 26219932
    [Abstract] [Full Text] [Related]

  • 2. Relative in vitro efficacy of the phosphate binders lanthanum carbonate and sevelamer hydrochloride.
    Autissier V, Damment SJ, Henderson RA.
    J Pharm Sci; 2007 Oct; 96(10):2818-27. PubMed ID: 17497733
    [Abstract] [Full Text] [Related]

  • 3. In-vitro Equilibrium Phosphate Binding Study of Sevelamer Carbonate by UV-Vis Spectrophotometry.
    Prasaja B, Syabani MM, Sari E, Chilmi U, Cahyaningsih P, Kosasih TW.
    Drug Res (Stuttg); 2018 Nov; 68(11):648-652. PubMed ID: 29895088
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of dietary phosphate absorption after single doses of lanthanum carbonate and sevelamer carbonate in healthy volunteers: a balance study.
    Martin P, Wang P, Robinson A, Poole L, Dragone J, Smyth M, Pratt R.
    Am J Kidney Dis; 2011 May; 57(5):700-6. PubMed ID: 21354682
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis.
    Fishbane S, Delmez J, Suki WN, Hariachar SK, Heaton J, Chasan-Taber S, Plone MA, Moe S.
    Am J Kidney Dis; 2010 Feb; 55(2):307-15. PubMed ID: 20042256
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative evaluation of the in vitro efficacy of lanthanum carbonate chewable tablets.
    Yang Y, Bykadi S, Carlin AS, Shah RB, Yu LX, Khan MA.
    J Pharm Sci; 2013 Apr; 102(4):1370-81. PubMed ID: 23334989
    [Abstract] [Full Text] [Related]

  • 11. Comparison of Phosphate Binding Capacities of PA21, A Novel Phosphate Binder, with those of other Phosphate Binders in vitro and in vivo.
    Yaguchi A, Yonekubo S, Maruyama I, Tatemichi S, Maruyama K, Kobayashi M.
    Drug Res (Stuttg); 2016 May; 66(5):262-9. PubMed ID: 26761712
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A phosphate binding assay for sevelamer hydrochloride by ion chromatography.
    Mazzeo JR, Peters RM, Hanus MR, Chen X, Norton KA.
    J Pharm Biomed Anal; 1999 May; 19(6):911-5. PubMed ID: 10698557
    [Abstract] [Full Text] [Related]

  • 15. Novel oral phosphate binder with nanocrystalline maghemite-phosphate binding capacity and pH effect.
    Nguyen TM, Müller RH, Taupitz M, Schnorr J, Hamm B, Wagner S.
    Int J Pharm; 2015 Mar 30; 482(1-2):21-6. PubMed ID: 25448551
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sevelamer worsens metabolic acidosis in hemodialysis patients.
    De Santo NG, Frangiosa A, Anastasio P, Marino A, Correale G, Perna A, Di Stazio E, Stellato D, Santoro D, Di Meglio E, Iacono G, Ciacci C, Savica V, Cirillo M.
    J Nephrol; 2006 Mar 30; 19 Suppl 9():S108-14. PubMed ID: 16736432
    [Abstract] [Full Text] [Related]

  • 18. Differences in gastrointestinal calcium absorption after the ingestion of calcium-free phosphate binders.
    Behets GJ, Dams G, Damment SJ, Martin P, De Broe ME, D'Haese PC.
    Am J Physiol Renal Physiol; 2014 Jan 01; 306(1):F61-7. PubMed ID: 24197066
    [Abstract] [Full Text] [Related]

  • 19. Clinical efficacy, safety and anti-inflammatory activity of two sevelamer tablet forms in patients on low-flux hemodialysis.
    Tzanno-Martins C, Biavo BM, Ferreira-Filho O, Ribeiro-Junior E, João-Luiz MV, Degaspari S, Scavone C, Kawamoto E.
    Int J Immunopathol Pharmacol; 2014 Jan 01; 27(1):25-35. PubMed ID: 24674676
    [Abstract] [Full Text] [Related]

  • 20. Development and validation of an ion chromatography method for the determination of phosphate-binding of lanthanum carbonate.
    Samy R, Faustino PJ, Adams W, Yu L, Khan MA, Yang Y.
    J Pharm Biomed Anal; 2010 Apr 06; 51(5):1108-12. PubMed ID: 20031362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.